Group One Trading’s Organogenesis Holdings ORGO Stock Holding History

Group One Trading’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$474	Buy	+200	New	+$693	﹤0.01%	7326
2025 Q2	–	Sell	-23,000	Closed	-$99.4K	–	8458
2025 Q1	$99.4K	Buy	+23,000	New	+$92.9K	﹤0.01%	4605
2024 Q1	–	Sell	-100	Closed	-$409	–	7725
2023 Q4	$409	Hold	100	–	–	﹤0.01%	7106
2023 Q3	$318	Sell	100 -3,900	-98%	-$12.4K	﹤0.01%	7398
2023 Q2	$13.3K	Hold	4,000	–	–	﹤0.01%	6227
2023 Q1	$8.52K	Buy	+4,000	New	+$9.88K	﹤0.01%	6027
2022 Q2	–	Sell	-4,300	Closed	-$33K	–	8316
2022 Q1	$33K	Buy	4,300 +1,900	+79%	+$14.7K	﹤0.01%	6414
2021 Q4	$22K	Sell	2,400 -4,600	-66%	-$48.9K	﹤0.01%	6920
2021 Q3	$100K	Buy	7,000 +6,500	+1,300%	+$101K	﹤0.01%	5912
2021 Q2	$8K	Buy	500 +300	+150%	+$5.59K	﹤0.01%	7610
2021 Q1	$4K	Buy	+200	New	+$2.71K	﹤0.01%	7292

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Group One Trading's ORGO Position: Q4 2025 in Review

Group One Trading sold out of Organogenesis Holdings (ORGO) in Q4 2025, closing a stake of 3,800 shares — an estimated $18.4K sold.

Group One Trading first reported a position in ORGO in Q4 2021 and held it in 11 quarters. The position peaked at $344K in Q4 2021. 147 funds tracked by Wall St. Rank hold ORGO as of Q4 2025.

Group One Trading reported no remaining Organogenesis Holdings position as of Q4 2025 after selling out during the quarter.
Group One Trading sold 3,800 Organogenesis Holdings shares in Q4 2025, an estimated $18.4K.
Group One Trading first reported a position in Organogenesis Holdings in Q4 2021 and held it in 11 quarters.
Group One Trading's Organogenesis Holdings position peaked at $344K in Q4 2021.
147 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.